Four publicly traded companies are drawing private equity attention as volatility stress pushes valuations below 7x EBITDA while trailing twelve-month free cash flow margins hold above 15%. The screen—applied by middle-market buyout desks and independent sponsors monitoring real-time deal flow—identifies names with three-year predictable revenue streams, management teams trading below comparable private transaction multiples, and balance sheets with room for $200M to $800M in incremental debt capacity.
The timing reflects elevated VIX readings persisting above 18 for eleven consecutive trading sessions, compressing public equity valuations faster than private market repricing cycles. Buyout shops running side-by-side public-versus-private comparables are finding a 120 to 180 basis point discount in public EV/EBITDA multiples relative to closed private transactions in Q4 2025. The dislocation creates entry points for sponsor-backed take-privates with hold periods targeting 2029 to 2031 exit windows, when private equity firms model normalized multiples returning to 8.5x to 9.5x EBITDA ranges on stable industrial and consumer businesses.
The four names passing the five-box screen—predictable cash flow, defensible margins, management stability, depressed valuation, and refinanceable capital structure—are generating inbound inquiries from 22 private equity firms with over $1B in dry powder allocated to North American buyouts. These are not distressed situations. They are profitable businesses trading at discounts because public market velocity punishes mid-cap equities lacking daily liquidity or quarterly earnings volatility. Private equity underwrites the same cash flows at higher multiples because the capital structure tolerates operational variance across 18 to 24 month windows without mark-to-market pressure.
Family offices launching forecasting tools for private markets exposure are simultaneously noting the arbitrage. Aleta's newly released Private Markets Forecasting module allows single-family offices to model portfolio exposure to private equity via co-investment vehicles and direct secondaries, while Stephen Twomey's published family office investment trends analysis highlights increased allocations to alternative funds pursuing private placements. The convergence is not coincidental. Allocators are modeling the public-to-private valuation gap as a 12 to 18 month window before public multiples normalize or private equity bids push take-private premiums above 25%, compressing returns.
Operators should track three follow-on events. First, watch for 13D filings from activist investors or private equity-affiliated special purpose vehicles on any of the four targets within 45 to 60 days—early signals of consortium formation. Second, monitor credit spreads on the companies' existing debt tranches; tightening spreads below +200 basis points over Treasuries suggest underwriters are preparing refinancing packages for sponsor-led recapitalizations. Third, observe insider buying by C-suite executives, particularly purchases above $500K in aggregate—management teams positioning for rollover equity in take-private transactions.
The screen will not stay clean. Public equity flows reverse faster than private equity deployment schedules, and the four names trading at 6.2x to 6.8x EBITDA today will either re-rate to 8x multiples as volatility subsides or disappear into sponsor portfolios by Q3 2026.